drugset / Trial / NCT01611363
A Phase 1 Study to Investigate the Mechanism of Action of Ipragliflozin
RandomizedCrossoverQuadruple-blindBasic science
Summary
In this study the effect of ipragliflozin on glucose homeostasis in healthy subjects and T2DM subjects, and the effect of exposure of ipragliflozin on urinary glucose excretion and plasma glucose in T2DM subjects will be investigated.
Timeline
- Start
- 2011-10-27
- Primary completion
- 2012-02-03
- Completion
- 2012-02-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ipragliflozin | Small molecule | — | Oral |